Autonomic Health

Helping the body move between activation, regulation and recovery

The autonomic nervous system is one of the body’s most important regulatory systems. It works continuously in the background, making thousands of small adjustments that help keep us stable, responsive and able to recover as circumstances change.

It helps regulate heart rate, blood pressure, circulation, breathing, digestion, body temperature, sleep, energy use and our response to physical and emotional stress. It also communicates closely with the immune, hormonal and metabolic systems.

Good autonomic health is therefore about much more than having a normal heart rate or blood pressure. It reflects the body’s ability to respond appropriately when something changes—and then return effectively towards a balanced, restorative state when the challenge has passed.

The vagus nerve plays a central role in this process. It is one of the body’s major communication pathways between the brain and internal organs, carrying information in both directions and helping coordinate functions involving the heart, lungs, digestive system, immune system and other organs.

Sympathetic overdrive and modern life

The autonomic nervous system continually adjusts the balance between different physiological states.

The sympathetic nervous system helps support alertness, activity and rapid responses to challenge. The parasympathetic nervous system, in which the vagus nerve plays an important role, supports functions associated with rest, digestion, recovery and regulation.

Both are essential. Short periods of increased sympathetic activity are completely normal—and often useful. The problem can arise when the body has difficulty moving out of a prolonged state of activation once the immediate need has passed.

This may be particularly relevant to modern life. Ongoing psychological pressure, constant stimulation, disrupted or inadequate sleep, limited recovery time, illness and chronic pain can repeatedly call upon the body’s stress-response systems. For some people, the result may be a body that increasingly behaves as though it needs to remain at an high level alertness and prepared for the next challenge.

This is sometimes described as sympathetic overdrive or excessive sympathetic activation.

Someone experiencing this pattern may notice:

difficulty relaxing or feeling persistently “switched on”
disturbed or unrefreshing sleep
fatigue despite feeling physiologically activated
digestive problems
increased sensitivity to pain
changes in heart rate or awareness of the heart beating
difficulty concentrating
reduced resilience to physical or emotional stress

Importantly, the goal is not to suppress the sympathetic nervous system. We need sympathetic activation for exercise, concentration, responding to challenges and many other normal activities.

What matters is flexibility—the ability to increase activation when it is needed and then transition effectively towards regulation and recovery when it is no longer required.

When autonomic regulation is struggling

Autonomic problems do not always present simply as sympathetic overdrive. When regulation becomes disrupted, the effects can appear in several seemingly unrelated parts of the body.

This may lead to heart-rate fluctuations, dizziness or postural symptoms, fatigue, poor exercise tolerance, temperature changes including hot flashes, digestive problems, disturbed sleep, or an exaggerated or prolonged response to stress.

For some people, the most noticeable feature is that the body seems to overreact to relatively small challenges—or takes much longer than expected to recover afterwards.

This may explain why impaired autonomic regulation can have such a substantial effect on everyday wellbeing. It can influence how someone feels when standing, exercising, eating, sleeping, dealing with stress—or simply getting through a normal day.

Where does aVNS fit?

This is one of the most natural applications of aVNS because the treatment directly stimulates a sensory pathway of the vagus nerve—a major component of the body’s brain–body regulatory network.

Clinical research has provided objective evidence that aVNS can influence autonomic function. Studies have reported changes in measures including heart-rate variability, vagal activity, sympathetic activity and cardiovascular responses, while research in specific autonomic disorders such as POTS has demonstrated measurable changes in the body’s response to standing.

This is important because the aim of aVNS is not simply to make someone feel calmer.

Nor does aVNS arbitrarily “switch off” the sympathetic nervous system or force the body into a state of relaxation. Rather, stimulation provides a signal into neural pathways involved in regulation, with the aim of helping the nervous system become more flexible in moving between activation, regulation and recovery at appropriate times.

That distinction may be particularly important in the context of modern life. If repeated stressors are continually pushing the body towards activation, a therapy that targets one of the body’s own regulatory pathways becomes especially valuable.

For someone experiencing symptoms associated with poor autonomic regulation—or simply finding that their body seems persistently “switched on”—the emerging research provides genuine reason for interest in aVNS.

Rather than treating activation and recovery as positive or negative states, the broader goal is to support the body’s ability to move appropriately between them: to respond when necessary, regulate effectively, and recover when the challenge has passed.

Heart-Rate Variability (HRV)

There has been an explosion of interest in heart-rate variability, or HRV, in recent years. Once mainly measured in research laboratories and specialist clinics, HRV is now routinely tracked by smartwatches, fitness trackers and smart rings.

HRV measures the tiny differences in timing from one heartbeat to the next. A healthy heart does not beat like a perfectly regular metronome. Instead, the interval between beats continually changes as the autonomic nervous system responds to breathing, activity, stress, rest and recovery.

In general, a higher resting HRV relative to your own normal range is associated with greater autonomic flexibility and recovery, while a persistent fall can accompany poor sleep, illness, psychological stress, heavy exercise or inadequate recovery.

There is no single “perfect” HRV. HRV also tends to decrease with age, and values vary considerably between individuals. Your own pattern over time is generally much more informative than comparing your number with someone else’s.

Why is HRV particularly interesting with aVNS?

The vagus nerve plays an important role in the beat-to-beat regulation of the heart. HRV therefore gives researchers something especially useful: an objective way of observing whether vagal stimulation is actually changing autonomic regulation.

Studies have reported improvements in HRV following aVNS, although results vary depending on the population, stimulation method and particular HRV measurement being examined. This supports the broader evidence that aVNS can influence autonomic function.

For Luminnova InnateSignal™, HRV can therefore provide an additional way of following response alongside changes that may be more noticeable in everyday life, such as:

better sleep · improved energy · greater stress tolerance · better exercise recovery · fewer autonomic symptoms · an improved general sense of wellbeing

The goal, however, is not to chase the highest possible HRV number.

HRV represents only one window into autonomic health. The more meaningful goal is improved autonomic flexibility and resilience—the ability to respond appropriately when the body is challenged and then return efficiently towards rest, recovery and balance.

Postural Orthostatic Tachycardia Syndrome (POTS)

POTS is a disorder of autonomic regulation in which the body has difficulty making the adjustments needed when a person moves from lying or sitting to standing.

Heart rate may rise excessively, and this can be accompanied by dizziness, palpitations, weakness, fatigue, brain fog, exercise intolerance and sometimes near-fainting.

POTS can have several contributing causes and does not behave identically in everyone. However, excessive sympathetic activity and inadequate parasympathetic or vagal regulation appear to be important in many patients.

This makes POTS an especially promising for exploring aVNS.

What has the research shown?

The early clinical findings are encouraging—and importantly, researchers have measured objective changes in autonomic function, not just changes in how patients said they felt.

In a randomized clinical trial, people with POTS used non-invasive vagus nerve stimulation every day for two months.

At the end of treatment, the excessive increase in heart rate that occurred when participants stood up was substantially smaller in those receiving active stimulation—approximately 18 beats per minute compared with 32 beats per minute in the comparison group.

In practical terms, their cardiovascular system was responding more normally to the challenge of standing.

But this was not the only change.

Researchers also found improvements in heart-rate variability (HRV), an objective measure of cardiac autonomic regulation, together with lower levels of inflammatory cytokines.

Particularly interesting was a reduction in two types of abnormal autoantibodies. These are antibodies that mistakenly target the body’s own proteins—in this case, receptors involved in regulating heart rate and blood-vessel function. Such antibodies may contribute to the abnormal cardiovascular regulation seen in some people with POTS.

Taken together, these findings suggest that aVNS may be influencing both the autonomic and immune processes that contribute to POTS—not simply reducing its symptoms.

This may also have wider relevance because POTS and other forms of autonomic dysfunction are commonly seen in Long COVID, other post-viral conditions and after vaccination. Long COVID research has provided further evidence that aVNS can produce meaningful changes in autonomic regulation, including HRV, while COVID-related studies have separately demonstrated effects on inflammatory and immune signaling.

Why is that important?

POTS is increasingly understood as more than simply “a fast heart rate when standing.”

In some patients, inflammation and abnormal antibodies may interfere with the receptors the body uses to regulate heart rate, blood pressure and circulation.

The fact that aVNS was associated not only with a smaller heart-rate rise but also with changes in these biological markers raises an intriguing possibility: vagal stimulation may be influencing some of the processes contributing to autonomic dysfunction rather than simply suppressing one of its symptoms.

Research in hyperadrenergic POTS, where excessive sympathetic nervous-system activity is particularly prominent, has added to this picture, with findings involving sympathetic activity, vagal regulation and cardiovascular responses to upright posture.

What might this mean for someone with POTS?

The research is still relatively early, and POTS is a complex condition with different underlying contributors in different people.

Nevertheless, these are unusually interesting findings because improvements have appeared at several levels—heart-rate control, autonomic regulation, inflammatory activity and abnormal antibodies.

For someone living with POTS, this provides a genuine reason for optimism that supporting vagal regulation may be a useful approach to improving the underlying autonomic imbalance, rather than focusing only on individual symptoms such as palpitations or dizziness.

For this reason, Luminnova InnateSignal™ may be considered as a supportive trial alongside established POTS measures, with response assessed not only by symptoms but, where appropriate, by changes in heart rate and other measures of autonomic function.

Click here to return to the Main aVNS Clinical Evidence Guide